Watchlist Price Alert

Adamas Pharmaceuticals In... (ADMS)

NASDAQ: ADMS · Real-Time Price · USD

8.22

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Adamas Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-57.4M	-105.19M	-131M	-89.49M	-60.06M
Depreciation & Amortization	851K	1.21M	1.46M	1.19M	808K
Stock-Based Compensation	6.43M	12.85M	15.79M	13.37M	10.57M
Other Working Capital	-37.05M	-79.89M	47.19M	56.21M	107.24M
Other Non-Cash Items	45.92M	91.07M	-32M	-47.22M	-5.25M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-46.5M	-80.72M	41.53M	55.32M	5.86M
Operating Cash Flow	-50.71M	-80.78M	-104.22M	-66.83M	-48.07M
Capital Expenditures	n/a	-18K	-1.06M	-1.26M	-1.62M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-68.94M	-93.87M	-200.35M	-62.51M	-103.53M
Sales Maturities Of Investments	123.88M	182.75M	132.08M	89.33M	78.44M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	54.94M	88.86M	-69.34M	25.57M	-26.71M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.65M	1.08M	138.85M	108.84M	65.41M
Financial Cash Flow	1.65M	1.08M	138.85M	108.84M	65.41M
Net Cash Flow	5.89M	9.17M	-34.71M	67.58M	-9.37M
Free Cash Flow	-50.71M	-80.8M	-105.29M	-68.08M	-49.69M